Opinion statement
With improved techniques and experience in endoscopic and percutaneous transhepatic biliary procedures, the initial management of biliary complications after liver transplantation has become increasingly nonoperative in nature. Although no prospective randomized trials that formally compare nonoperative and operative therapy for post-transplant biliary complications have been performed, numerous case series and other descriptive studies have demonstrated that nonoperative therapies can be as effective as surgical therapy, and the less invasive nature of the endoscopic and percutaneous techniques make them the preferred initial therapy of choice in selected circumstances. Indeed, for small biliary leaks and early anastomotic strictures, nonoperative management has become the initial therapy of choice, with operative intervention being reserved for cases in which the endoscopic or percutaneous approach fails to resolve the underlying complication. Despite the increasing use of endoscopic or percutaneous treatment modalities to treat post-transplant biliary complication, operative intervention remains a potential definitive therapy for most complications and generally results in the most durable outcomes with the least need for reintervention. Operative intervention is still the treatment of choice for significant biliary anastomotic disruptions, massive biliary leaks, or any biliary complication that is associated with severe intraabdominal or systemic infection.
Similar content being viewed by others
References and Recommended Reading
Pascher A, Neuhas P: Bile duct complications after liver transplantation. Transpl Int 2005, 18:627–642.
Guichelaar MM, Benson JT, Malinchoc M, et al.: Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant 2003, 3:885–890.
Chen W, Gluud C: Bile acids for liver transplanted patients. Cochrane Database Syst Rev 2005, 3:CD005442.
Guy JE, Qian P, Lowell JA, Peters MG: Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl 2005, 11:1252–1257.
Soderdahl G, Nowak G, Duraj F, et al.: Ursodeoxycholic acid increases bile flow and affects bile composition in the early postoperative phase following liver transplantation. Transpl Int 1998, 11(Suppl 1):S231–S238.
Caroli-Bosc FX, Iliadis A, Salmon L, et al.: Ursodeoxycholic acid modulates cyclosporine A oral absorption in liver transplant recipients. Fundam Clin Pharmacol 2000, 14:601–609.
Roumilhac D, Poyet G, Sergent G, et al.: Long-term results of percutaneous management for anastomotic biliary stricture after orthotopic liver transplantation. Liver Transpl 2003, 9:394–400.
Denys A, Chevallier P, Doenz F, et al.: Interventional radiology in the management of complications after liver transplantation. Eur Radiol 2004, 14:431–439.
Saad WE, Saad NE, Davies MG, et al.: Transhepatic balloon dilation of anastomotic biliary strictures in liver transplant recipients: the significance of a patent hepatic artery. J Vasc Interv Radiol 2005, 16:1221–1228.
Saad WE, Davies MG, Saad NE, et al.: Transhepatic dilation of anastomotic biliary strictures in liver transplant recipients with use of a combined cutting and conventional balloon protocol: technical safety and efficacy. J Vasc Interv Radiol 2006, 17:837–843.
Davidson BR, Rai R, Nandy A, et al.: Results of choledo-chojejunostomy in the treatment of biliary complications after liver transplantation in the era of nonsurgical therapies. Liver Transpl 2000, 6:201–206.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scarborough, J.E., Desai, D.M. Treatment options for biliary complications after orthotopic liver transplantation. Curr Treat Options Gastro 10, 81–89 (2007). https://doi.org/10.1007/s11938-007-0060-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11938-007-0060-9